Switch to:
More From Other Websites
Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO)... May 25 2017
National Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer Community May 22 2017
Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments May 18 2017
TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : May 18, 2017 May 18 2017
Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug? May 17 2017
TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : May 17, 2017 May 17 2017
Edited Transcript of TSRO earnings conference call or presentation 9-May-17 8:15pm GMT May 16 2017
TESARO Partners With Clinigen to Initiate European Managed Access Program for Niraparib in Patients... May 11 2017
Tesaro reports 1Q loss May 09 2017
TESARO Announces First-Quarter 2017 Operating Results May 09 2017
Investor Network: TESARO, Inc. to Host Earnings Call May 09 2017
KITE Plunges, Take Sector With It May 08 2017
Neurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as... May 01 2017
TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to... May 01 2017
Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space Apr 27 2017
TESARO Initiates Registrational Development Program for Anti-PD-1 Antibody TSR-042 Apr 27 2017
TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission Apr 26 2017
TESARO to Announce First-Quarter 2017 Financial Results on May 9, 2017 Apr 25 2017
Tesaro Announces Participation in Two Investor Conferences Apr 25 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK